Trials / Unknown
UnknownNCT05187481
Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer
Efficacy Evaluation of Jianpi Huatan Decoction in the Treatment of Advanced Colorectal Cancer and Analysis of Dominant Population Characteristics and Methylation Characteristics
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will take progression-free survival and overall survival as the main evaluation indexes, to evaluate the Efficacy of Jianpi Huatan Decoction in the Treatment of Advanced Colorectal Cancer. Decision Trees and Discriminant Analysis will be used to analyze the characteristics of dominant population combined with clinical data of patients. DNA methylation of the subjects will be detected to study the methylation characteristics of the preponderant population of Jianpi Huatan Decoction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Jianpi Huatan dispensing granule | once a day in the morning and evening, 30 days as a course of treatment, a total of 3 courses. |
| DRUG | Placebo granule | once a day in the morning and evening, 30 days as a course of treatment, a total of 3 courses. |
Timeline
- Start date
- 2021-11-15
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2022-01-11
- Last updated
- 2022-01-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05187481. Inclusion in this directory is not an endorsement.